www.medscape.com (must register)
>>>snip
March 2, 2011 — The US Food and Drug Administration (FDA) is taking action against companies that manufacture, distribute, or market oral agents that are not approved by the FDA. The drugs are prescribed for the treatment of coughs, colds, and allergies in the United States.
According to the FDA, companies that have previously listed products subject to today's action are required to stop manufacturing the products within 90 days and to stop shipping the products within 180 days. Companies that have not previously listed products subject to today's action with FDA are expected to stop manufacturing and shipping their products immediately.
"Many health care providers are unaware of the unapproved status of drugs and have continued to unknowingly prescribe them because the drugs' labels do not disclose that they lack FDA approval," according to an FDA news release.
During an FDA press conference today, officials said there has been limited reporting of adverse events related to these products, but that these adverse events are probably significantly underreported, and this has the spurred the FDA to take action.
Here is the list:
http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/ucm245106.htm